Drug-to-Antibody Ratio (DAR)
Categories: biopharmaceuticals
Definition
The distribution of different payload attachments (the cytotoxic drug) to an Antibody-Drug Conjugate (ADC), or the average of different drug to antibody loads for an ADC.
Related Content & Resources
Case Study
Iksuda Therapeutics – Assessment of Drug Antibody Ratios (DARs)
Iksuda requested an assessment of DARs for their antibody-drug-conjugate (ADC) product in plasma samples derived from mouse Pharmacokinetic (PK) studies.
Read More